Page 64 - 32

17. Surh, Y. J. Cancer chemoprevention with dietary phytochemicals. Natural Reviews in Cancer. 2003; 3: 768-780.
18. Stramba-Badiale, M., Fox, K. M.,Priori, S. G., Collins, P., Daly, C.,Graham, I., Jonsson, B., Schenck,Gustafsson,
K., & tendera, M.Cardiovascular diseases in women: a statement from the policy conference of the European
Society of Cardiology.Eur. Heart J. 2006; 27: 994-1005.
19. Wang, C. Z., Mehendale, S. R., & Yuan, C. S. Commonly used antioxidant botanicals: active constituents and
their potential role on cardiovascular illness. Am. J. Chin. Med. 2007; 35(4): 543-558.
20. Riccioni, G., Mancini, B., Di Ilio, E.,Bucciarelli, T. & D'Orazio, N.Protective effect of lycopene in cardiovascular
disease. Eur. Rev. Med.Pharmacol. Sci. 2008;12: 183-190.
21. Dwyer, J. Overview: dietary approaches for reducing cardiovascular disease risks. J. Nutr. 1995; 125: 656-665.
22. Hastler, C. M., Kundrat, S., & Wool D.Functional foods and cardiovascular disease. Current Atherosclerosis
Reports. Consumption: benefits and risks. Critical reviews in Food Science & Nutrition. 2000; 2: 467-475.
23. Choudhary, M. & Grover, K.Development of functional food products in relation to obesity.Functional Foods
in Health and Disease.2012; 2(6): 188-197.
24. Martorell, R., Kettel Khan, L., Hughes, M. L., & Grummer-Strawn, L. M.Overweight and obesity in preschool
children from developing countries. Int.J. Obes. Relat. Metab. Disord. 2000;24(8): 959-967.
25. Lobstein T, Rigby N. IOTF. International Obesity Task Force. Obesity in Europe, EU Platform Briefing Paper,
in collaboration with European Association for the Study of Obesity.2005.
26. Pereira, M. A. & Ludwig, D. S. Dietary fibre and body weight regulation: observations and mechanisms. Ped
Clin N America. 2001; 48(4): 969-980.
27. Faulks RM, Southon S. Assessing the bioavailability of nutraceuticals. In:Delivery and Controlled Release of
Bioactives in Foods and Nutraceuticals,1st ed. N Garti, editor. Cambridge, UK:Woodhead 2008; 3-25.
28. Rubio L, Macia A, Motilva M-J. Impact of various factors on pharmacokinetics of bioactive polyphenols: an
overview.Curr. Drug Metab. 2014; 15:62–76.
29. Mackie A. Interaction of food ingredient and nutraceutical delivery systems with the human gastrointestinal
tract. In Encapsulation Technologies and Delivery Systems for Food Ingredients and Nutraceuticals, ed. N Garti, DJ
McClements. Cambridge, UK:Woodhead. 2012; 49-70.
30. Ubbink J, Kruger J. Physical approaches for the delivery of active ingredients in foods. Trends FoodSci.
Technol. 2006;17(5):244–54.
31. Augustin MA, Sanguansri L.Challenges in developing delivery systems for food additives, nutraceuticals and
dietary supplements. In Encapsulation Technologies and Delivery Systems for Food Ingredients and Nutraceuticals,
1st ed. N Garti, DJ McClements, Cambridge, UK:Woodhead. 2012; 19-48.
32. McClements DJ. Requirements for food ingredient and nutraceutical delivery systems. In Encapsulation
Technologies and Delivery Systems for Food Ingredients and Nutraceuticals, ed. N Garti, DJ McClements,.
Cambridge,UK: Woodhead. 2012; 3-18.
33. Livney YD. Milk proteins as vehicles for bioactives. Curr. Opin. Coll. Interface Sci. 2010; 15:73–83.
34. Mellema M, Van Benthum WAJ, Boer B, Von Harras J, Visser A. Wax encapsulation of water-soluble
compounds for application in foods. J.Microencapsul. 2006; 23(7):729–740.
35. McClements DJ, Decker EA, Weiss J. Emulsion-based delivery systems for lipophilic bioactive components.J.
Food Sci. 2007; 72(8): 109–124.
36. McClements DJ, Decker EA, Park Y, Weiss J. Structural design principles for delivery of bioactive components
in nutraceuticals and functional foods.Crit. Rev. Food Sci. Nutr. 2009;49(6):577–606.
37. Augustin MA, Sanguansri L. Encapsulation of bioactives. In Food Materials Science: Principles and Practice,
ed. JM Aguilera, PJ Lilford.New York: Springer. 2008; 577-601.
38. Gouin S. Microencapsulation: industrial appraisal of existing technologies and trends. Trends Food Sci.
Technol. 2004;15(7):330–347.
39. Onwulata CI. Encapsulation of new active ingredients. Annu. Rev. Food Sci.Technol. 2012; 3:183–202.
40. Ezhilarasi PN, Karthik P, Chhanwal N, Anandharamakrishnan C.Nanoencapsulation techniques for food
bioactive components: a review. Food Bioprocess Technol. 2013; 6(3):628–647.
41. Ruxton CHS, Reed SC, Simpson MJA, Millington KJ. The health benefits of omega-3 polyunsaturated fatty
acids: a review of evidence. J. Hum. Nutr. Diet.2004; 17 (5): 449-459.
42. Taneja A, Singh H. Challenges for the delivery of long-chain n-3 fatty acids in functional foods. Annu. Rev.
Food Sci.Technol. 2012; 5:105–123.
43. Chen B, McClements DJ, Decker EA.Design of foods with bioactive lipids for improved health. Annu. Rev.
Food Sci.Technol. 2013; 4:35–56.
44. Yao M,Xiao H, McClements DJ. Delivery of lipophilic bioactives:assembly, disassembly, and reassembly of
lipid nanoparticles. Annu. Rev. Food Sci. Technol. 2014; 5:53–81.
45. Iannitti T, Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin. Nutr. 2010;
29(6):701–725.
46. Rokka S, Rantam¨aki P. Protecting probiotic bacteria by microencapsulation: challenges for industrial
applications. Eur. Food Res.Technol. 2010; 231(1):1–12.
47. Heidebach T, F, orst P, Kulozik U. Microencapsulation of probiotic cells for food applications. Crit. Rev. Food
Sci. Nutr. 2012; 52(4):291–311.

62